Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 21, 1997

View Archived Issues

Shaman patents new antifungal agents

New anticonvulsants from Howard University

Celltech reports new PDE IV inhibitors

Merck & Co. claims NMDA and AMPA antagonists for neurologic indications

Human IL-9 reported in patent literature

Sumitomo reports novel hCNTF variant

Suntory reports new agents for circulatory disorders

New 5-HT1A receptor ligands reported by Bayer

New cardiovascular agents from Sigma-Tau

Company Profile: CyberChemics

Company Profile: Calydon

n-Docosanol efficacy demonstrated in herpes labialis

Efficacy of Fujirebio antiulcer drug demonstrated

Hoechst launches antidiabetic drug in Germany

Function of breast cancer gene described

Viracept licensed to Roche

Hybridon granted patent coverage for orally administered hybrid compounds

First market introductions for Bondronat

Millennium and ChemGenics merge

New market for Mivacron

Synsorb product enters clinical trials

Allelix refocuses drug development program

Asta seeks rights to impotency Rx

GS-840 progresses through clinical trials

URSO to be evaluated as chemopreventive for colorectal cancer

Altus receives grant for nerve agent neutralization

Sequana and PE Applied Biosystems form Chinese joint venture

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...